Last reviewed · How we verify
NCT07354048
Impact Of Thyroid Dysfunction on Liver Function Tests
trial testing Control group in Thyroid Disease in 100 participants. Currently enrolling.
30 January 2026
Quick facts
| Lead sponsor | Sohag University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 14 July 2025 |
| Primary completion | 30 January 2026 |
| Estimated completion | 30 January 2026 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Control group — full drug profile →
- Patients with hypothyroidism or hyperthyroidism that are controlled on treatment
- Patients with hypothyroidism or hyperthyroidism that are not controlled on treatment
- Patients with hypothyroidism or hyperthyroidism that are firstly discovered
Conditions studied
- Thyroid Disease — all drugs for Thyroid Disease →
Sponsor
Sohag University
Who can join
Adults 20 to 60, any sex, with Thyroid Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to evaluate the effect of thyroid dysfunction on liver function tests.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07354048
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Control group
Trials testing the same drug.
- NCT07510555 — The Effect of a Mindfulness-Based Stress Reduction Program Applied to Nulliparous Pregnant Women · NA · not yet recruiting
- NCT07327918 — Effect of Epidural Needle Injection on Catheter Placement Success During Painless Labour · Phase 3 · not yet recruiting
- NCT07494292 — Personalised Active Self-management of Sleep Apnea Program · NA · not yet recruiting
- NCT07483775 — Feasibility and Health-economic Evaluation of Remote Clinical Monitoring Enabling Same-day Discharge After Bariatric Sur · NA · not yet recruiting
- NCT07505472 — Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Wit · Phase 2, PHASE3 · recruiting
Other recruiting trials for Thyroid Disease
Currently open trials in the same condition.
- NCT07294989 — The Effective Blood Concentration of Ciprofol · recruiting
- NCT06296420 — Dysphagia After Thyroidectomy · recruiting
- NCT05117853 — Autofluorescence and Indocyanine Green to Avoid Hypocalcemia After Thyroidectomy · Phase 3 · recruiting
Other Sohag University trials
Trials by the same sponsor.
- NCT07119905 — Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patie · not yet recruiting
- NCT07512219 — Comparison Between Greater Occipital Nerve Block and Pulsed Radiofrequency in the Management of Chronic Migraine · NA · not yet recruiting
- NCT07519694 — Comparative Study Between Different Additives to Lidocaine 2٪ for Peribulbar Block in Vitreoretinal Surgery · NA · not yet recruiting
- NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
- NCT07523386 — Compartive Study Between Cannulated Screw and Kws in Fixation of Distal Radius · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07354048 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sohag University
- Last refreshed: 21 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07354048.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing